CEO SUMMARY: For labs currently processing prostate biopsy cases with five or more cores and for those pathologists interpreting those cases, there is a lack of clarity about new Medicare policies. As one example, risk of an audit is significant because of recent guidance issued by one Medicare contractor. Another source of risk for labs […]
Lawyer Advises on Risk Of Prostate Biopsy Audits
All labs could face federal audits for failing to comply with new rules on prostate biopsies
- By Joseph Burns
- > From the Volume XIX No. 13 - September 17, 2012 Issue
- Tags: anatomic pathologist, Anatomic pathology, billing medicare, biopsies, biopsy, cpt, cpt code, cytopathology, false claims act, federal false claims act, HCPCS codes, jane pine, jane pine wood, lab manager, lab managers, laboratories, Medicare, Medicare Part B, pathologists, pathology practice, prostate biopsy, rac audit, surgical pathology
